Related Experiment Videos
[Antioxidants and cardiovascular disease]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 19, 2000
Summary
Antioxidant vitamins like E and C may reduce cardiovascular disease (CVD) risk. While some trials show no benefit, recent data suggest dietary antioxidants limit atherosclerotic CVD progression.
Area of Science:
- Biochemistry
- Nutrition Science
- Cardiovascular Medicine
Context:
- Oxygen-free radical reactions are linked to chronic diseases, including atherosclerotic cardiovascular disease (CVD).
- Epidemiologic studies suggest a correlation between higher intake of antioxidant vitamins (E and C) and lower CVD morbidity and mortality.
- However, randomized trials have yielded inconsistent results regarding the efficacy of antioxidant supplementation for CVD prevention.
Purpose:
- To review the role of oxygen-free radical reactions in chronic diseases.
- To evaluate the association between antioxidant vitamin intake and cardiovascular disease outcomes.
- To reconcile conflicting findings from observational studies and randomized trials on antioxidants and CVD.
Summary:
- While epidemiologic data support a protective role for antioxidant vitamins (E and C) against CVD, many randomized trials have failed to demonstrate significant benefits.
- Potential reasons for trial discrepancies include lack of specific CVD endpoints, insufficient duration, and suboptimal dosages of vitamin E.
- Emerging evidence indicates that dietary antioxidants from food sources may play a role in mitigating the progression of atherosclerotic CVD.
Impact:
- Highlights the ongoing debate and complexity surrounding antioxidant supplementation for cardiovascular health.
- Suggests that the source and form of antioxidants (dietary vs. supplemental) may be critical.
- Reinforces the importance of considering study design and dosage in evaluating antioxidant efficacy for preventing atherosclerotic cardiovascular disease.